These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3432720)

  • 1. [Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
    Cristani A; Cioni G; Minetto G; Di Pancrazio L; Anderlini D; Grandi S; Vezzelli C; Zirilli E; Zeneroli ML; Ventura E
    Recenti Prog Med; 1987 Oct; 78(10):431-3. PubMed ID: 3432720
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin-fibrinogen degradation products in hepatic cirrhosis.
    Bulajić M; Kovacević N; Lalić M; Rolović Z
    Acta Med Iugosl; 1977; 31(4):333-8. PubMed ID: 596236
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of D-dimer in patients with liver cirrhosis.
    Violi F; Ferro D; Saliola M; Quintarelli C; Alessandri C
    Thromb Haemost; 1989 Dec; 62(4):1149-50. PubMed ID: 2617464
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulating levels of products of fibrinogen and fibrin monomer degradation in liver cirrhosis].
    Rocha E; López Borrasca A
    Rev Med Univ Navarra; 1974; 18(3-4):143-7. PubMed ID: 4471076
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
    Buraschi J; Sack ES
    Sangre (Barc); 1972; 17(1):35-42. PubMed ID: 5016795
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis.
    Ardaillou N; Yvart J; Le Bras P; Larrieu MJ
    Thromb Haemost; 1980 Dec; 44(3):146-9. PubMed ID: 7466742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Examination of fibrin degradation products in cirrhosis of liver (author's transl)].
    Pstruzinová H; Rovenská A; Goderová Z; Kristan M
    Cas Lek Cesk; 1980 Jan; 119(1):7-11. PubMed ID: 7371051
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 15. Levels of plasma fibrinogen and D-dimer in subjects with white-coat hypertension.
    Coban E; Ozdoğan M; Akçit F
    J Hum Hypertens; 2004 Apr; 18(4):291-2. PubMed ID: 15037880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group.
    Violl F; Basili S; Ferro D; Quintarelli C; Alessandril C; Cordova C
    Thromb Haemost; 1996 Aug; 76(2):177-83. PubMed ID: 8865526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Products of degradation of fibrinogen in surgical patients].
    Golovastova GI; Guseĭnov ChS
    Lab Delo; 1975; (6):368-71. PubMed ID: 51128
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of fibrinogen degradation product in severe liver disorders by immunoblotting.
    Tanaka M; Ohkita T
    Tohoku J Exp Med; 1987 Nov; 153(3):179-87. PubMed ID: 3433274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.